This inventor holds 1 USPTO granted patent and 6 published patent applications and 1 EPO patent. Top assignees: Genentech, Inc., Hoffmann-La Roche Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2026
Title: The Innovations of Edmond Huatung Teng
Introduction
Edmond Huatung Teng is a notable inventor based in San Mateo, CA. He has made significant contributions to the field of medicine, particularly in the treatment of relapsing multiple sclerosis. His innovative approach has led to the development of a unique method that utilizes a specific inhibitor to address this challenging condition.
Latest Patents
One of Teng's key patents is titled "Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase." This patent outlines methods for treating Relapsing Multiple Sclerosis (RMS) by administering approximately 200 mg of fenebrutinib twice daily, or an equivalent amount of a pharmaceutically acceptable salt thereof. This innovative treatment offers new hope for individuals suffering from RMS.
Career Highlights
Throughout his career, Edmond Teng has worked with prominent companies in the pharmaceutical industry, including Genentech, Inc. and Hoffmann-La Roche Inc. His experience in these organizations has allowed him to develop and refine his expertise in drug development and treatment methodologies.
Collaborations
Teng has collaborated with several esteemed colleagues in his field, including Hideki Garren and Aurelien Viaccoz. These partnerships have contributed to the advancement of his research and the successful implementation of his innovative ideas.
Conclusion
Edmond Huatung Teng's contributions to the treatment of relapsing multiple sclerosis exemplify the impact of innovation in medicine. His work continues to inspire advancements in therapeutic approaches for complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile